Form 8-K - Current report:
SEC Accession No. 0001104659-25-025547
Filing Date
2025-03-19
Accepted
2025-03-19 16:05:16
Documents
13
Period of Report
2025-03-18
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm259776d1_8k.htm   iXBRL 8-K 26180
  Complete submission text file 0001104659-25-025547.txt   201805

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mist-20250318.xsd EX-101.SCH 3036
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mist-20250318_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mist-20250318_pre.xml EX-101.PRE 22373
16 EXTRACTED XBRL INSTANCE DOCUMENT tm259776d1_8k_htm.xml XML 3816
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38899 | Film No.: 25752696
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)